Pseudohypoaldosteronism type 2B

MONDO:0013777

Any pseudohypoaldosteronism type 2 in which the cause of the disease is a mutation in the WNK4 gene.

Also known as: PHA2B, WNK4 pseudohypoaldosteronism type 2, pseudohypoaldosteronism type 2 caused by mutation in WNK4, pseudohypoaldosteronism, type 2B, pseudohypoaldosteronism, type IIB

1 clinical trial for this condition and its sub-types, 0 tagged with Pseudohypoaldosteronism type 2B itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Pseudohypoaldosteronism type 2 (2)

Including sub-types (1) Tagged with Pseudohypoaldosteronism type 2B (0)

Trials to join now! 1

Could a diabetes drug protect kidneys in children with genetic disease?

Disease control Recruiting now

This study tests whether adding dapagliflozin (a diabetes drug) to standard care reduces protein leakage in the urine of children with hereditary kidney diseases. About 44 children will receive either dapagliflozin plus standard care or standard care alone for 12 weeks, then swit…

Phase 3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Pseudohypoaldosteronism type 2B

Where it sits in the disease tree

Could a diabetes drug protect kidneys in children with genetic disease?